These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7128137)

  • 61. Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel.
    Gaspard UJ; Buret J; Gillain D; Romus MA; Lambotte R
    Contraception; 1985 Apr; 31(4):395-408. PubMed ID: 3159546
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
    Crook D; Godsland IF; Worthington M; Felton CV; Proudler AJ; Stevenson JC
    Am J Obstet Gynecol; 1993 Nov; 169(5):1183-9. PubMed ID: 8238183
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Serum lipids and lipoproteins during treatment with oral contraceptives containing natural and synthetic oestrogens. A controlled double-blind investigation.
    Bostofte E; Hemmingsen L; Møller KJ; Serup J; Weber T
    Acta Endocrinol (Copenh); 1978 Apr; 87(4):855-64. PubMed ID: 347855
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Variations in serum copper and ceruloplasmin activity following a long term intake of combined oral contraceptives in Iranian women.
    Kamyab S; Baghdiantz A; Jenati S
    J Endocrinol Invest; 1980; 3(2):173-5. PubMed ID: 7391523
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Six-month carbohydrate metabolism studies in women using oral contraceptives containing gestodene and ethinyl estradiol.
    Spellacy WN; Tsibris JC; Hunter-Bonner DL; Smalling S; Chez RA; Angel JL; O'Brien WF
    Contraception; 1992 Jun; 45(6):533-9. PubMed ID: 1617962
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Differential effects on bone density of progestogen-only methods for contraception in premenopausal women.
    Naessen T; Olsson SE; Gudmundson J
    Contraception; 1995 Jul; 52(1):35-9. PubMed ID: 8521712
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparison of the metabolic effects of oral contraceptive and nonhormonal contraceptive use in women over 40 years old.
    Suwikrom S; Jaisamrarn U
    Contraception; 2005 Mar; 71(3):183-7. PubMed ID: 15722067
    [TBL] [Abstract][Full Text] [Related]  

  • 68. d-Norgestrel concentrations in maternal plasma, milk, and child plasma during administration of oral contraceptives to nursing women.
    Nilsson S; Nygren KG; Johansson ED
    Am J Obstet Gynecol; 1977 Sep; 129(2):178-84. PubMed ID: 900181
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The effect of oral contraceptives on antiaggregatory prostacyclin and proaggregatory thromboxane A2 in humans.
    Ylikorkala O; Puolakka J; Viinikka L
    Am J Obstet Gynecol; 1982 Mar; 142(5):573-6. PubMed ID: 7036746
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Progestational agents and blood coagulation. V. Changes induced by sequential oral contraceptive therapy.
    Mink IB; Courey NG; Niswander KR; Moore RH; Lillie MA; Ambrus JL
    Am J Obstet Gynecol; 1974 Jun; 119(3):401-5. PubMed ID: 4275088
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Metabolic changes during treatment with two different progestogens.
    Refn H; Kjaer A; Lebech AM; Borggaard B; Schierup L; Bremmelgaard A
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):374-7. PubMed ID: 2115298
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Thyroid functions of women taking oral contraceptives.
    Barsivala V; Virkar K
    Contraception; 1974 Mar; 9(3):305-14. PubMed ID: 4442279
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The effect of triphasic oral contraceptives on plasma lipids and lipoproteins.
    Patsch W; Brown SA; Gotto AM; Young RL
    Am J Obstet Gynecol; 1989 Nov; 161(5):1396-401. PubMed ID: 2686455
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A norgestimate-containing oral contraceptive: review of clinical studies.
    Kafrissen ME
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1196-202. PubMed ID: 1415446
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study.
    Rosing J; Middeldorp S; Curvers J; Christella M; Thomassen LG; Nicolaes GA; Meijers JC; Bouma BN; Büller HR; Prins MH; Tans G
    Lancet; 1999 Dec; 354(9195):2036-40. PubMed ID: 10636369
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Haemostasis profile in smoking and nonsmoking women taking low-dose oral contraceptives.
    Fruzzetti F; Ricci C; Fioretti P
    Contraception; 1994 Jun; 49(6):579-92. PubMed ID: 8070263
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
    Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparison of ethinylestradiol and mestranol in sequential-type oral contraceptives in their effects on blood glucose and serum insulin in oral glucose tolerance tests.
    Leis D; Botterman P; Ermler R; Maurer U
    Fertil Steril; 1977 Jul; 28(7):737-40. PubMed ID: 872954
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Differential lipemic and proteinemic response to oral ethinyl estradiol and parenteral estradiol cypionate.
    Buckman MT; Johnson J; Ellis H; Srivastava L; Peake GT
    Metabolism; 1980 Sep; 29(9):803-5. PubMed ID: 7412555
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A quantitative study of the pregnancy zone protein in sera of woman taking oral contraceptives.
    Damber MG; von Schoultz B; Solheim F; Stigbrand T
    Am J Obstet Gynecol; 1976 Feb; 124(3):289-92. PubMed ID: 55075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.